Cloning and characterization of developmental endothelial locus-1: An embryonic endothelial cell protein that binds the αvβ3 integrin receptor

  1. Chiaki Hidai1,
  2. Thomas Zupancic2,
  3. Kalyani Penta3,8,
  4. Adel Mikhail2,
  5. Masatoshi Kawana1,
  6. Elena E. Quertermous3,
  7. Yoshikazu Aoka1,3,8,
  8. Masafumi Fukagawa4,
  9. Yasuhisa Matsui5,
  10. Doros Platika2,
  11. Robert Auerbach6,
  12. Brigid L.M. Hogan7,
  13. Ralph Snodgrass2, and
  14. Thomas Quertermous3,8,9
  1. Departments of 3Medicine, 4Molecular Physiology and Biophysics, and 7Cell Biology and the Howard Hughes Medical Institute, Vanderbilt University Medical School, Nashville, Tennessee 37232 USA; 1Tokyo Women’s Medical College, Tokyo 162, Japan; 2Progenitor, Inc., Menlo Park, California 94025 USA; Third Department of Internal Medicine, University of Tokyo, Tokyo, Japan; 5Department of Cell Biology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan; 6Department of Zoology, University of Wisconsin, Madison, Wisconsin 53202 USA

Abstract

We have taken advantage of an enhancer trap event in a line of transgenic mice to identify a unique developmentally regulated endothelial cell locus (Del1). The protein encoded in this locus contains three EGF-like repeats homologous to those in Notch and related proteins, including an EGF-like repeat that contains an RGD motif, and two discoidin I-like domains. Del1 is shown to be a matrix protein and to promote adhesion of endothelial cells through interaction with the αvβ3 integrin receptor. Embryonic endothelial-like yolk sac cells expressing recombinant Del1 protein, or grown on an extracellular matrix containing Del1 protein, are inhibited from forming vascular-like structures. Expression of Del1 protein in the chick chorioallantoic membrane leads to loss of vascular integrity and promotes vessel remodeling. Del1 is thus a new ligand for the αvβ3 integrin receptor and may function to regulate vascular morphogenesis or remodeling in embryonic development.

Keywords

Footnotes

  • 8 Present address: Division of Cardiology, Stanford University Medical School, Stanford, California 94305 USA.

  • 9 Corresponding author.

  • E-MAIL tomq1{at}leland.stanford.edu; FAX (650) 725-2178.

    • Received August 14, 1997.
    • Accepted November 6, 1997.
| Table of Contents

Life Science Alliance